Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021

AUSTIN, Texas, April 1, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeu…